VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$13.16
+1.09 (+9.03%)
As of Feb 8, 2:00 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 29.07M 27.10M 30.53M
Net Income 5.84M 4.59M 6.02M
EPS
Profit Margin 20.1% 16.9% 19.7%
Rev Growth +18.1% +12.4% +4.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 92.40M 104.31M 115.91M
Total Equity 143.94M 152.98M 165.14M
D/E Ratio 0.64 0.68 0.70
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.15M 7.65M 7.71M
Free Cash Flow 6.21M 7.09M 6.33M